These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 25104286)

  • 1. Mapping p53 mutations in low-grade glioma: a voxel-based neuroimaging analysis.
    Wang YY; Zhang T; Li SW; Qian TY; Fan X; Peng XX; Ma J; Wang L; Jiang T
    AJNR Am J Neuroradiol; 2015 Jan; 36(1):70-6. PubMed ID: 25104286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anatomical localization of isocitrate dehydrogenase 1 mutation: a voxel-based radiographic study of 146 low-grade gliomas.
    Wang Y; Zhang T; Li S; Fan X; Ma J; Wang L; Jiang T
    Eur J Neurol; 2015 Feb; 22(2):348-54. PubMed ID: 25318355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression level of human miR-34a correlates with glioma grade and prognosis.
    Gao H; Zhao H; Xiang W
    J Neurooncol; 2013 Jun; 113(2):221-8. PubMed ID: 23529798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Voxel-wise radiogenomic mapping of tumor location with key molecular alterations in patients with glioma.
    Tejada Neyra MA; Neuberger U; Reinhardt A; Brugnara G; Bonekamp D; Sill M; Wick A; Jones DTW; Radbruch A; Unterberg A; Debus J; Heiland S; Schlemmer HP; Herold-Mende C; Pfister S; von Deimling A; Wick W; Capper D; Bendszus M; Kickingereder P
    Neuro Oncol; 2018 Oct; 20(11):1517-1524. PubMed ID: 30107597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subgroup characteristics of insular low-grade glioma based on clinical and molecular analysis of 42 cases.
    Tang C; Zhang ZY; Chen LC; Sun Z; Zhang Y; Qin Z; Yao Y; Zhou LF
    J Neurooncol; 2016 Feb; 126(3):499-507. PubMed ID: 26586262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IDH mutation, 1p19q codeletion and ATRX loss in WHO grade II gliomas.
    Leeper HE; Caron AA; Decker PA; Jenkins RB; Lachance DH; Giannini C
    Oncotarget; 2015 Oct; 6(30):30295-305. PubMed ID: 26210286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Value of O-(2-[18F]-Fluoroethyl)-L-Tyrosine-Positron Emission Tomography Imaging for Histopathologic Characteristics and Progression-Free Survival in Patients with Low-Grade Glioma.
    Bette S; Gempt J; Delbridge C; Kirschke JS; Schlegel J; Foerster S; Huber T; Pyka T; Zimmer C; Meyer B; Ringel F
    World Neurosurg; 2016 May; 89():230-9. PubMed ID: 26855307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Voxel-based clustered imaging by multiparameter diffusion tensor images for glioma grading.
    Inano R; Oishi N; Kunieda T; Arakawa Y; Yamao Y; Shibata S; Kikuchi T; Fukuyama H; Miyamoto S
    Neuroimage Clin; 2014; 5():396-407. PubMed ID: 25180159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of Tumor Contrast Enhancement Predict the Prognosis of Anaplastic Gliomas with IDH1 Mutation.
    Wang YY; Wang K; Li SW; Wang JF; Ma J; Jiang T; Dai JP
    AJNR Am J Neuroradiol; 2015 Nov; 36(11):2023-9. PubMed ID: 26316565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interplay among BRAF, p16, p53, and MIB1 in pediatric low-grade gliomas.
    Horbinski C; Nikiforova MN; Hagenkord JM; Hamilton RL; Pollack IF
    Neuro Oncol; 2012 Jun; 14(6):777-89. PubMed ID: 22492957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatostatin receptor 2A in gliomas: Association with oligodendrogliomas and favourable outcome.
    Kiviniemi A; Gardberg M; Kivinen K; Posti JP; Vuorinen V; Sipilä J; Rahi M; Sankinen M; Minn H
    Oncotarget; 2017 Jul; 8(30):49123-49132. PubMed ID: 28467778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Genetic Profiles and Prognosis of High-Grade Gliomas Using Quantitative and Qualitative MRI Features: A Focus on G3 Gliomas.
    Hong EK; Choi SH; Shin DJ; Jo SW; Yoo RE; Kang KM; Yun TJ; Kim JH; Sohn CH; Park SH; Won JK; Kim TM; Park CK; Kim IH; Lee ST
    Korean J Radiol; 2021 Feb; 22(2):233-242. PubMed ID: 32932560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anatomical localization of p53 mutated tumors: A radiographic study of human glioblastomas.
    Zhang T; Wang Y; Fan X; Ma J; Li S; Jiang T; Wang L
    J Neurol Sci; 2014 Nov; 346(1-2):94-8. PubMed ID: 25130928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Role of BRAF Mutation in Low-Grade Gliomas: Meta-analysis.
    Kai Z; Dingyang L; Zhuanyi Y
    World Neurosurg; 2021 Mar; 147():42-46. PubMed ID: 33316486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study on the correlation between STAT‑1 and mutant p53 expression in glioma.
    Yang W; Wang H; Ju H; Dou C
    Mol Med Rep; 2018 Jun; 17(6):7807-7812. PubMed ID: 29620180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival in males with glioma and gastric adenocarcinoma correlates with mutant p53 residual transcriptional activity.
    Fischer NW; Prodeus A; Gariépy J
    JCI Insight; 2018 Aug; 3(15):. PubMed ID: 30089713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of p53 and prognosis in children with malignant gliomas.
    Pollack IF; Finkelstein SD; Woods J; Burnham J; Holmes EJ; Hamilton RL; Yates AJ; Boyett JM; Finlay JL; Sposto R;
    N Engl J Med; 2002 Feb; 346(6):420-7. PubMed ID: 11832530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of IDH mutation, 1p/19q deletion, and PTEN loss delineates prognosis in clinical low-grade diffuse gliomas.
    Sabha N; Knobbe CB; Maganti M; Al Omar S; Bernstein M; Cairns R; Çako B; von Deimling A; Capper D; Mak TW; Kiehl TR; Carvalho P; Garrett E; Perry A; Zadeh G; Guha A; Sidney Croul
    Neuro Oncol; 2014 Jul; 16(7):914-23. PubMed ID: 24470545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localizing seizure-susceptible brain regions associated with low-grade gliomas using voxel-based lesion-symptom mapping.
    Wang Y; Qian T; You G; Peng X; Chen C; You Y; Yao K; Wu C; Ma J; Sha Z; Wang S; Jiang T
    Neuro Oncol; 2015 Feb; 17(2):282-8. PubMed ID: 25031032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IDH1 status is significantly different between high-grade thalamic and superficial gliomas.
    Zuo M; Li M; Chen N; Yu T; Kong B; Liang R; Wang X; Mao Q; Liu Y
    Cancer Biomark; 2017 Aug; 20(2):183-189. PubMed ID: 28869450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.